{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:19:16Z","timestamp":1772119156870,"version":"3.50.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T00:00:00Z","timestamp":1746489600000},"content-version":"vor","delay-in-days":5,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100009104","name":"Universit\u00e0 degli Studi di Modena e Reggio Emilia","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100009104","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2025,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Although patients with hematological malignancies carry a non-negligible risk of venous thromboembolic events (VTE), no risk assessment models (RAMs) have been developed and validated to predict this risk during their hospital stay. Moreover, the performance of RAMs developed to predict the thromboembolic and hemorrhagic risk in hospitalized medical patients has never been assessed in this specific population. In this observational study we sought to assess the incidence of VTE and hemorrhagic events (HE), to evaluate pharmacological prophylaxis use, and to test existing RAMs for TE and HE (Padua Predictions Score, PPS, and Improve Bleeding Score, IBS, respectively) in a population of 514 hematological patients at their first hospital admission. 165 patients were found to be at high thromboembolic and 114 at high hemorrhagic risk according to PPS and IBS; a total of 148 patients received pharmacological prophylaxis with low-molecular weight heparin (LMWH). An incidence of VTE (3.11%) and HE (1.75%) was found, with most thrombotic (15\/16) and hemorrhagic (8\/9) events occurring in patients not receiving prophylaxis. At the univariate analysis, the diagnosis of acute leukemia was significantly associated with an increased risk of VTE, whereas prophylaxis was found to be protective. However, at the multivariate analysis the statistical significance was lost for both of these variables (HR\u2009=\u20092.76,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.218 and HR\u2009=\u20090.22,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.170, respectively). PPS poorly performed in this population, but no other factors associated with VTE were found. Larger, multicenter studies to develop better RAMs tailored to HM patients are needed to improve VTE management in this population.\n                  <\/jats:p>","DOI":"10.1007\/s00277-025-06397-9","type":"journal-article","created":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T22:37:20Z","timestamp":1746484640000},"page":"2963-2971","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Venous thromboembolic risk in hematological hospitalized patients: a retrospective study"],"prefix":"10.1007","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-2953-7193","authenticated-orcid":false,"given":"Stefano","family":"Cordella","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valeria","family":"Coluccio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riccardo","family":"Cuoghi Costantini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"D\u2019Amico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Luppi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Marietta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,6]]},"reference":[{"issue":"2","key":"6397_CR1","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1160\/TH16-08-0615","volume":"117","author":"C Ay","year":"2017","unstructured":"Ay C, Pabinger I, Cohen AT (2017) Cancer-associated venous thromboembolism: burden, mechanisms, and management. Thromb Haemost 117(2):219\u2013230. https:\/\/doi.org\/10.1160\/TH16-08-0615","journal-title":"Thromb Haemost"},{"issue":"14","key":"6397_CR2","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1182\/blood.2020007338","volume":"137","author":"FI Mulder","year":"2021","unstructured":"Mulder FI, Horv\u00e1th-Puh\u00f3 E, van Es N et al (2021) Venous thromboembolism in cancer patients: a population-based cohort study. Blood 137(14):1959\u20131969. https:\/\/doi.org\/10.1182\/blood.2020007338","journal-title":"Blood"},{"issue":"6","key":"6397_CR3","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1016\/j.jtha.2023.02.029","volume":"21","author":"A Falanga","year":"2023","unstructured":"Falanga A, Marchetti M (2023) Cancer-associated thrombosis: enhanced awareness and pathophysiologic complexity. J Thromb Haemost 21(6):1397\u20131408. https:\/\/doi.org\/10.1016\/j.jtha.2023.02.029","journal-title":"J Thromb Haemost"},{"issue":"1","key":"6397_CR4","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41572-022-00336-y","volume":"8","author":"AA Khorana","year":"2022","unstructured":"Khorana AA, Mackman N, Falanga A et al (2022) Cancer-associated venous thromboembolism. Nat Rev Dis Primers 8(1):11. https:\/\/doi.org\/10.1038\/s41572-022-00336-y","journal-title":"Nat Rev Dis Primers"},{"key":"6397_CR5","doi-asserted-by":"publisher","unstructured":"Ku GH, White RH, Chew HK, Harvey DJ, Zhou H, Wun (2009) Venous thromboembolism in patients with acute leukemia: incidence, risk factors, and effect on survival. Blood 113(17):3911\u20133917. https:\/\/doi.org\/10.1182\/blood-2008-08-175745","DOI":"10.1182\/blood-2008-08-175745"},{"issue":"6","key":"6397_CR6","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1097\/CCO.0b013e3283592331","volume":"24","author":"A Falanga","year":"2012","unstructured":"Falanga A, Marchetti M, Russo L (2012) Venous thromboembolism in the hematologic malignancies. Curr Opin Oncol 24(6):702\u2013710. https:\/\/doi.org\/10.1097\/CCO.0b013e3283592331","journal-title":"Curr Opin Oncol"},{"issue":"1","key":"6397_CR7","doi-asserted-by":"publisher","first-page":"101353","DOI":"10.1016\/j.beha.2022.101353","volume":"35","author":"TF Wang","year":"2022","unstructured":"Wang TF, Leader A, Sanfilippo K (2022) Review on thrombosis and bleeding in hematological malignancy. Best Pract Res Clin Haematol 35(1):101353. https:\/\/doi.org\/10.1016\/j.beha.2022.101353","journal-title":"Best Pract Res Clin Haematol"},{"key":"6397_CR8","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1111\/jth.12265","volume":"11","author":"A Casini","year":"2013","unstructured":"Casini A, Fontana P, Lecompte T (2013) Thrombotic complications of myeloproliferative neoplasms: risk assessment and risk guided management. J Thromb Haemost 11:1215\u20131227. https:\/\/doi.org\/10.1111\/jth.12265","journal-title":"J Thromb Haemost"},{"issue":"10","key":"6397_CR9","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.3324\/haematol.2012.064444","volume":"97","author":"SY Kristinsson","year":"2012","unstructured":"Kristinsson SY, Pfeiffer RM, Bj\u00f6rkholm M, Schulman S, Landgren O (2012) Thrombosis is associated with inferior survival in multiple myeloma. Haematologica 97(10):1603\u20131607. https:\/\/doi.org\/10.3324\/haematol.2012.064444","journal-title":"Haematologica"},{"issue":"Suppl 2","key":"6397_CR10","doi-asserted-by":"publisher","first-page":"S23","DOI":"10.1016\/S0049-3848(14)50004-7","volume":"133","author":"A Mahajan","year":"2014","unstructured":"Mahajan A, Wun T, Chew H, White RH (2014) Lymphoma and venous thromboembolism: influence on mortality. Thromb Res 133(Suppl 2):S23. https:\/\/doi.org\/10.1016\/S0049-3848(14)50004-7","journal-title":"Thromb Res"},{"key":"6397_CR11","doi-asserted-by":"publisher","unstructured":"Poh C, Brunson A, Keegan T, Wun T, Mahajan A (2020) Incidence of Upper Extremity Deep Vein Thrombosis in Acute Leukemia and Effect on Mortality. TH Open 2020;4(4):e309-e317. https:\/\/doi.org\/10.1055\/s-0040-1718883","DOI":"10.1055\/s-0040-1718883"},{"issue":"7","key":"6397_CR12","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1002\/rth2.12411","volume":"4","author":"MW Schoen","year":"2020","unstructured":"Schoen MW, Carson KR, Luo S et al (2020) Venous thromboembolism in multiple myeloma is associated with increased mortality. Res Pract Thromb Haemost 4(7):1203\u20131210. https:\/\/doi.org\/10.1002\/rth2.12411","journal-title":"Res Pract Thromb Haemost"},{"issue":"1","key":"6397_CR13","doi-asserted-by":"publisher","first-page":"102342","DOI":"10.1016\/j.rpth.2024.102342","volume":"8","author":"I Goncalves","year":"2024","unstructured":"Goncalves I, Lewis C, Grainger B, Dring R, Lee N, Pasricha SR, Szer J, Mason K (2024) Thrombosis in patients with immune thrombocytopenia: incidence, risk, and clinical outcomes. Res Pract Thromb Haemost 8(1):102342. https:\/\/doi.org\/10.1016\/j.rpth.2024.102342","journal-title":"Res Pract Thromb Haemost"},{"issue":"11","key":"6397_CR14","doi-asserted-by":"publisher","first-page":"2870","DOI":"10.1111\/jth.15027","volume":"18","author":"B Tse","year":"2020","unstructured":"Tse B, Lim G, Sholzberg M, Pavenski K (2020) Describing the point prevalence and characteristics of venous thromboembolism in patients with thrombotic thrombocytopenic purpura. J Thromb Haemost 18(11):2870\u20132877. https:\/\/doi.org\/10.1111\/jth.15027","journal-title":"J Thromb Haemost"},{"issue":"10","key":"6397_CR15","doi-asserted-by":"publisher","first-page":"4902","DOI":"10.1111\/jth.15027","volume":"111","author":"AA Khorana","year":"2208","unstructured":"Khorana AA, Kuderer NM, Culakova E, Lyman GH, Francis CW (2208) Development and validation of a predictive model for chemotherapy-associated thrombosis. Blood 111(10):4902\u20134907. https:\/\/doi.org\/10.1111\/jth.15027","journal-title":"Blood"},{"issue":"24","key":"6397_CR16","doi-asserted-by":"publisher","first-page":"5377","DOI":"10.1182\/blood-2010-02-270116","volume":"116","author":"C Ay","year":"2010","unstructured":"Ay C, Dunkler D, Marosi C et al (2010) Prediction of venous thromboembolism in cancer patients. Blood 116(24):5377\u20135382. https:\/\/doi.org\/10.1182\/blood-2010-02-270116","journal-title":"Blood"},{"key":"6397_CR17","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s11739-012-0784-y","volume":"7","author":"M Verso","year":"2012","unstructured":"Verso M, Agnelli G, Barni S, Gasparini G, LaBianca R (2012) A modified Khorana risk assessment score for venous thromboembolism in cancer patients receiving chemotherapy: the protecht score. Intern Emerg Med 7:291\u2013292. https:\/\/doi.org\/10.1007\/s11739-012-0784-y","journal-title":"Intern Emerg Med"},{"issue":"10","key":"6397_CR18","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1634\/theoncologist.2016-0414","volume":"22","author":"GT Gerotziafas","year":"2017","unstructured":"Gerotziafas GT, Taher A, Abdel-Razeq H, COMPASS\u2013CATWorking Group et al (2017) A predictive score for thrombosis associated with breast, colorectal, lung, or ovarian cancer: the prospective COMPASS Cancer-Associated thrombosis study. Oncologist 22(10):1222\u20131231. https:\/\/doi.org\/10.1634\/theoncologist.2016-0414","journal-title":"Oncologist"},{"issue":"7","key":"6397_CR19","doi-asserted-by":"publisher","first-page":"e289","DOI":"10.1016\/S2352-3026(18)30063-2","volume":"5","author":"I Pabinger","year":"2018","unstructured":"Pabinger I, van Es N, Heinze G et al (2018) A clinical prediction model for cancer-associated venous thromboembolism: a development and validation study in two independent prospective cohorts. Lancet Haematol 5(7):e289\u2013e298. https:\/\/doi.org\/10.1016\/S2352-3026(18)30063-2","journal-title":"Lancet Haematol"},{"issue":"16","key":"6397_CR20","doi-asserted-by":"publisher","first-page":"2911","DOI":"10.1200\/JCO.22.0025","volume":"41","author":"A Mu\u00f1oz","year":"2023","unstructured":"Mu\u00f1oz A, Ay C, Grilz E et al (2023) A Clinical-Genetic risk score for predicting Cancer-Associated venous thromboembolism: A development and validation study involving two independent prospective cohorts. J Clin Oncol 41(16):2911\u20132925. https:\/\/doi.org\/10.1200\/JCO.22.0025","journal-title":"J Clin Oncol"},{"issue":"2","key":"6397_CR21","doi-asserted-by":"publisher","first-page":"e230010","DOI":"10.1001\/jamanetworkopen.2023.0010","volume":"6","author":"CA Cella","year":"2023","unstructured":"Cella CA, Knoedler M, Hall M et al (2023) Validation of the ONKOTEV risk prediction model for venous thromboembolism in outpatients with Cancer. JAMA Netw Open 6(2):e230010. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.0010","journal-title":"JAMA Netw Open"},{"issue":"12","key":"6397_CR22","doi-asserted-by":"publisher","first-page":"3613","DOI":"10.1007\/s00277-023-05463-4","volume":"102","author":"SA L\u00f3pez","year":"2023","unstructured":"L\u00f3pez SA, Tejeda Ram\u00f3n MC, Morales Helguera A et al (2023) Validation of venous thromboembolism predictive model in hematologic malignancies. Ann Hematol 102(12):3613\u20133620. https:\/\/doi.org\/10.1007\/s00277-023-05463-4","journal-title":"Ann Hematol"},{"issue":"10","key":"6397_CR23","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1002\/ajh.24466A","volume":"91","author":"D Antic","year":"2016","unstructured":"Antic D, Milic N, Nikolovski S, Todorovic M, Bila J, Djurdjevic P et al (2016) Development and validation of multivariable predictive model for thromboembolic events in lymphoma patients. Am J Hematol 91(10):1014\u20131019. https:\/\/doi.org\/10.1002\/ajh.24466A","journal-title":"Am J Hematol"},{"issue":"11","key":"6397_CR24","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1002\/ajh.25603","volume":"94","author":"KM Sanfilippo","year":"2019","unstructured":"Sanfilippo KM, Luo S, Wang TF et al (2019) Predicting venous thromboembolism in multiple myeloma: development and validation of the IMPEDE VTE score. Am J Hematol 94(11):1176\u20131184. https:\/\/doi.org\/10.1002\/ajh.25603","journal-title":"Am J Hematol"},{"key":"6397_CR25","doi-asserted-by":"publisher","first-page":"901887","DOI":"10.3389\/fphar.2022.901887","volume":"13","author":"Y Chen","year":"2022","unstructured":"Chen Y, Lei H, Wang W, Zhu J et al (2022) Characteristics and predictors of venous thromboembolism among lymphoma patients undergoing chemotherapy: A cohort study in China. Front Pharmacol 13:901887. https:\/\/doi.org\/10.3389\/fphar.2022.901887","journal-title":"Front Pharmacol"},{"issue":"5","key":"6397_CR26","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.3390\/cancers12051291","volume":"12","author":"S Hohaus","year":"2020","unstructured":"Hohaus S, Bartolomei F, Cuccaro A, Maiolo E, Alma E, D\u2019Al\u00f2 F et al (2020) Venous thromboembolism in lymphoma: risk stratification and antithrombotic prophylaxis. Cancers (Basel) 12(5):1291. https:\/\/doi.org\/10.3390\/cancers12051291","journal-title":"Cancers (Basel)"},{"issue":"2","key":"6397_CR27","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1055\/s-0039-3400303","volume":"120","author":"F Al-Ani","year":"2020","unstructured":"Al-Ani F, Wang YP, Lazo-Langner A (2020) Development of a clinical prediction rule for venous thromboembolism in patients with acute leukemia. Thromb Haemost 120(2):322\u2013328. https:\/\/doi.org\/10.1055\/s-0039-3400303","journal-title":"Thromb Haemost"},{"issue":"4","key":"6397_CR28","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1007\/s00277-022-04770-6","volume":"101","author":"F Martella","year":"2022","unstructured":"Martella F, Cerrano M, Di Cuonzo D, Secreto C, Olivi M, Apolito V et al (2022) Frequency and risk factors for thrombosis in acute myeloid leukemia and high-risk myelodysplastic syndromes treated with intensive chemotherapy: a two centers observational study. Ann Hematol 101(4):855\u2013867. https:\/\/doi.org\/10.1007\/s00277-022-04770-6","journal-title":"Ann Hematol"},{"issue":"22","key":"6397_CR29","doi-asserted-by":"publisher","first-page":"5640","DOI":"10.3390\/cancers14225640","volume":"14","author":"G Paterno","year":"2022","unstructured":"Paterno G, Palmieri R, Forte V et al (2022) Predictors of early thrombotic events in adult patients with acute myeloid leukemia: A Real-World experience. Cancers (Basel) 14(22):5640. https:\/\/doi.org\/10.3390\/cancers14225640","journal-title":"Cancers (Basel)"},{"issue":"1","key":"6397_CR30","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s12959-024-00607-6","volume":"22","author":"M Mitrovic","year":"2024","unstructured":"Mitrovic M, Pantic N, Bukumiric Z et al (2024) Venous thromboembolism in patients with acute myeloid leukemia: development of a predictive model. Thromb J 22(1):37. https:\/\/doi.org\/10.1186\/s12959-024-00607-6","journal-title":"Thromb J"},{"key":"6397_CR31","doi-asserted-by":"publisher","first-page":"n1106","DOI":"10.1136\/bmj.n1106","volume":"373","author":"D Horner","year":"2013","unstructured":"Horner D, Goodacre S, Davis S, Burton N, Hunt BJ (2013) Which is the best model to assess risk for venous thromboembolism in hospitalised patients? BMJ 373:n1106. https:\/\/doi.org\/10.1136\/bmj.n1106","journal-title":"BMJ"},{"key":"6397_CR32","doi-asserted-by":"publisher","first-page":"2450","DOI":"10.1111\/j.1538-7836.2010","volume":"8","author":"S Barbar","year":"2010","unstructured":"Barbar S, Noventa F, Rossetto V et al (2010) A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua prediction score. J Thromb Haemost 8:2450\u20132457. https:\/\/doi.org\/10.1111\/j.1538-7836.201004044.x","journal-title":"J Thromb Haemost"},{"issue":"1","key":"6397_CR33","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1378\/chest.09-3081","volume":"139","author":"H Decousus","year":"2011","unstructured":"Decousus H, Tapson VF, Bergmann JF, IMPROVE Investigators et al (2011) Factors at admission associated with bleeding risk in medical patients: findings from the IMPROVE investigators. Chest 139(1):69\u201379. https:\/\/doi.org\/10.1378\/chest.09-3081","journal-title":"Chest"},{"issue":"2","key":"6397_CR34","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1007\/s00134-023-07287-2","volume":"50","author":"FC Carini","year":"2024","unstructured":"Carini FC, Angriman F, Scales DC, Munshi L, Burry LD, Sibai H, Mehta S, Ferreyro BL, SELECTION study group (2024) Venous thromboembolism in critically ill adult patients with hematologic malignancy: a population-based cohort study. Intensive Care Med 50(2):222\u2013233. https:\/\/doi.org\/10.1007\/s00134-023-07287-2","journal-title":"Intensive Care Med"},{"key":"6397_CR35","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1111\/jth.12108","volume":"11","author":"M Vardi","year":"2013","unstructured":"Vardi M, Ghanem-Zoubi NO, Zidan R, Yurin V, Bitterman H (2013) Venous thromboembolism and the utility of the Padua prediction score in patients with sepsis admitted to internal medicine departments. J Thromb Haemost 11:467\u2013473. https:\/\/doi.org\/10.1111\/jth.12108","journal-title":"J Thromb Haemost"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-025-06397-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-025-06397-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-025-06397-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T02:37:29Z","timestamp":1749091049000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-025-06397-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["6397"],"URL":"https:\/\/doi.org\/10.1007\/s00277-025-06397-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5394153\/v1","asserted-by":"object"}]},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"5 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki, and was approved by on April 9th, 2024, by the Comitato Etico Area Vasta Emilia Nord \u2013 protocol 127\/2024\/OSS*\/AOUMO SIRER ID 7322.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"According to the Italian current regulations for retrospective studies, informed consent was obtained from patients who were reachable, while it was not required for those who were unreachable or deceased. Their data were used in compliance with the additional steps outlined by the current privacy regulations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}